| CEBPA–double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features F Mannelli, V Ponziani, S Bencini, MI Bonetti, M Benelli, I Cutini, ... haematologica 102 (3), 529, 2016 | 81 | 2016 |
| Venetoclax-based regimens for relapsed/refractory acute myeloid leukemia in a real-life setting: a retrospective single-center experience M Piccini, S Pilerci, M Merlini, P Grieco, B Scappini, S Bencini, B Peruzzi, ... Journal of Clinical Medicine 10 (8), 1684, 2021 | 24 | 2021 |
| Preliminary results of the GIMEMA LAL2317 sequential chemotherapy-blinatumomab front-line trial for newly diagnosed adult Ph-negative B-lineage ALL patients R Bassan, S Chiaretti, I Della Starza, O Spinelli, A Santoro, L Elia, A Vitale, ... HemaSphere 5 (S2), 8, 2021 | 21 | 2021 |
| Albumin Cys34 adducted by acrolein as a marker of oxidative stress in ischemia-reperfusion injury during hepatectomy E Witort, S Capaccioli, M Becatti, C Fiorillo, G Batignani, V Pavoni, ... Free Radical Research 50 (8), 831-839, 2016 | 20 | 2016 |
| Sequential chemotherapy and blinatumomab to improve minimal residual disease in adult Ph-B-lineage acute lymphoblastic leukemia. final results of the phase II Gimema LAL2317 Trial S Chiaretti, I Della Starza, A Santoro, O Spinelli, L Elia, MS De Propris, ... Blood 142, 826, 2023 | 18 | 2023 |
| Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating … A Candoni, D Lazzarotto, C Papayannidis, M Piccini, G Nadali, ... American Journal of Hematology 98 (4), E80-E83, 2023 | 13 | 2023 |
| The role of venetoclax in relapsed/refractory acute myeloid leukemia: past, present, and future directions M Piccini, F Mannelli, G Coltro Bioengineering 10 (5), 591, 2023 | 10 | 2023 |
| Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic … D Lazzarotto, I Tanasi, A Vitale, M Piccini, M Dargenio, F Giglio, ... Annals of Hematology 102 (5), 1099-1109, 2023 | 10 | 2023 |
| Multilineage dysplasia as assessed by Immunophenotype in acute myeloid leukemia: a prognostic tool in a genetically undefined category F Mannelli, S Bencini, M Piccini, G Gianfaldoni, MI Bonetti, B Peruzzi, ... Cancers 12 (11), 3196, 2020 | 9 | 2020 |
| COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report S Chiaretti, M Bonifacio, R Agrippino, F Giglio, M Annunziata, A Curti, ... Haematologica 107 (8), 1955, 2022 | 8 | 2022 |
| Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm M Piccini, GG Loscocco, G Gianfaldoni, P Grieco, G Palmieri, S Pilerci, ... Annals of Hematology 99, 907-909, 2020 | 7 | 2020 |
| Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia F Mannelli, M Piccini, S Bencini, G Gianfaldoni, B Peruzzi, R Caporale, ... Haematologica 109 (1), 60, 2023 | 4 | 2023 |
| A case of disseminated blastic plasmocytoid dendritic cell neoplasm GG Loscocco, M Piccini, F Vergoni, AM Vannucchi, A Bosi American Journal of Hematology 93 (11), 1433-1434, 2018 | 4 | 2018 |
| Dissecting Ph-like ALL: the role of genomic lesion and minimal residual disease in refining outcome D Cardinali, I Della Starza, V Bellomarino, M Beldinanzi, M Di Trani, ... Blood 140 (Supplement 1), 6350-6351, 2022 | 3 | 2022 |
| Visceral leishmaniasis GG Loscocco, M Piccini New England Journal of Medicine 380 (4), 379-379, 2019 | 3 | 2019 |
| A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype–phenotype Association S Roncareggi, K Girardi, F Fioredda, L Pedace, L Arcuri, R Badolato, ... Journal of Clinical Immunology 43 (8), 2192-2207, 2023 | 2 | 2023 |
| Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group M Defina, D Lazzarotto, F Guolo, P Minetto, NS Fracchiolla, F Giglio, ... Leukemia research 122, 106963, 2022 | 2 | 2022 |
| Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia F Mannelli, G Gianfaldoni, S Bencini, M Piccini, I Cutini, MI Bonetti, ... American Journal of Hematology 95 (11), 1304-1313, 2020 | 2 | 2020 |
| Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus … D Lazzarotto, M Cerrano, C Papayannidis, S Chiaretti, F Mosna, ... Haematologica 110 (1), 55, 2024 | 1 | 2024 |
| A Rare Onset of T-Lymphoid Blast Crisis in Chronic Myeloid Leukemia with Two Distinct Blast Populations A Mongia, F Romano, S Ciullini Mannurita, B Peruzzi, S Bencini, D Parrini, ... Hematology Reports 16 (3), 413-420, 2024 | 1 | 2024 |
